Literature DB >> 7961834

Primary structure and functional expression of human Glycyl-tRNA synthetase, an autoantigen in myositis.

Q Ge1, E P Trieu, I N Targoff.   

Abstract

Two identical cDNAs encoding human glycyl-tRNA synthetase were isolated from K562 and HEL cell lambda gt11 libraries by screening with "anti-EJ" autoantibodies from a patient with dermatomyositis, previously shown to specifically inhibit this enzyme. The sequenced cDNA had 2,385 base pairs, with a predicted protein of 685 amino acids and M(r) 77,500. The antigen reactive with anti-EJ was immunoaffinity-purified from HeLa cells, and two proteolytic peptides matched areas of the predicted amino acid sequence. The sequence was 61.6% identical with that of silk moth glycyl-tRNA synthetase. Several very highly conserved regions were identified, including the single class II synthetase motif region and an N-terminal region similar to one found in at least three other synthetases. Near identity in other regions suggested that they also had important functions. Expression of the cDNA in Escherichia coli yielded a protein of expected size that reacted with the autoantibodies and was active as glycyl-tRNA synthetase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961834

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  A fragment of human TrpRS as a potent antagonist of ocular angiogenesis.

Authors:  Atsushi Otani; Bonnie M Slike; Michael I Dorrell; John Hood; Karen Kinder; Karla L Ewalt; David Cheresh; Paul Schimmel; Martin Friedlander
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

2.  A novel adenoviral vector-mediated mouse model of Charcot-Marie-Tooth type 2D (CMT2D).

Authors:  Ah Jung Seo; Youn Ho Shin; Seo Jin Lee; Doyeun Kim; Byung Sun Park; Sunghoon Kim; Kyu Ha Choi; Na Young Jeong; Chan Park; Ji-Yeon Jang; Youngbuhm Huh; Junyang Jung
Journal:  J Mol Histol       Date:  2013-08-30       Impact factor: 2.611

3.  Detection of anti-PL-12 autoantibodies by ELISA using a recombinant antigen; study of the immunoreactive region.

Authors:  J R García-Lozano; M F González-Escribano; R Rodríguez; J L Rodriguez-Sanchez; I N Targoff; I Wichmann; A Núñez-Roldán
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

4.  The crystal structures of the α-subunit of the α(2)β (2) tetrameric Glycyl-tRNA synthetase.

Authors:  Kemin Tan; Min Zhou; Rongguang Zhang; Wayne F Anderson; Andrzej Joachimiak
Journal:  J Struct Funct Genomics       Date:  2012-10-06

5.  The glycyl-tRNA synthetase of Chlamydia trachomatis.

Authors:  E A Wagar; M J Giese; B Yasin; M Pang
Journal:  J Bacteriol       Date:  1995-09       Impact factor: 3.490

6.  A human aminoacyl-tRNA synthetase as a regulator of angiogenesis.

Authors:  Keisuke Wakasugi; Bonnie M Slike; John Hood; Atsushi Otani; Karla L Ewalt; Martin Friedlander; David A Cheresh; Paul Schimmel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

7.  Inactivation of a glycyl-tRNA synthetase leads to an arrest in plant embryo development.

Authors:  U Uwer; L Willmitzer; T Altmann
Journal:  Plant Cell       Date:  1998-08       Impact factor: 11.277

8.  Wide cross-species aminoacyl-tRNA synthetase replacement in vivo: yeast cytoplasmic alanine enzyme replaced by human polymyositis serum antigen.

Authors:  T L Ripmaster; K Shiba; P Schimmel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

9.  Operational RNA code for amino acids: species-specific aminoacylation of minihelices switched by a single nucleotide.

Authors:  D Hipps; K Shiba; B Henderson; P Schimmel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

10.  Functional and crystal structure analysis of active site adaptations of a potent anti-angiogenic human tRNA synthetase.

Authors:  Xiang-Lei Yang; Min Guo; Mili Kapoor; Karla L Ewalt; Francella J Otero; Robert J Skene; Duncan E McRee; Paul Schimmel
Journal:  Structure       Date:  2007-07       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.